Rezulin (troglitazone) for Type II diabetes

    Rezulin (troglitazone) for Type II diabetes will be out soon. Parke-Davis is launching it this month in the U.S...possibly later this year in Canada.

    This is the first drug in a new class...called "glitazones." These drugs are very useful...they reduce insulin resistance.

    Troglitazone stimulates the uptake of glucose into skeletal muscle cells...and decreases glucose production in the liver.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote